Cytomegalovirus in Solid Organ Transplant Recipients

被引：237
|
作者：
Humar, A. [1 ]
Snydman, D. [2 ]
机构：
[1] Univ Alberta, Dept Med, Transplant Infect Dis, Edmonton, AB, Canada
[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
Cytomegalovirus; ganciclovir; preemptive therapy; prophylaxis; GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS; IMMUNE GLOBULIN PROPHYLAXIS; AMPLICOR CMV MONITOR; CLINICAL UTILITY; VIRAL-LOAD; ORAL GANCICLOVIR; VALGANCICLOVIR PROPHYLAXIS; INTRAVENOUS GANCICLOVIR; LIVER-TRANSPLANTATION; RENAL-TRANSPLANTATION;
D O I：
10.1111/j.1600-6143.2009.02897.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S78 / S86
页数：9
相关论文
共 50 条
  • [21] Strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients - Response
    Kalil, AC
    Stoner, J
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (06) : 457 - 457
  • [22] Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir
    Fellay, J
    Venetz, JP
    Pascual, M
    Aubert, JD
    Seydoux, C
    Meylan, PR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (07) : 1781 - 1782
  • [23] Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
    Hodson, Elisabeth M.
    Ladhani, Maleeka
    Webster, Angela C.
    Strippoli, Giovanni F. M.
    Craig, Jonathan C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (02):
  • [24] Cytomegalovirus infection in pediatric solid organ transplant recipients and role of prophylaxis
    Nance, Gwen
    Serluco, Anastacia
    Deshpande, Shri
    Garro, Rouba
    George, Roshan
    Kelleman, Michael
    Yildrim, Inci
    Liverman, Rochelle
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [25] Recent advances in cytomegalovirus infection management in solid organ transplant recipients
    Grossi, Paolo Antonio
    Peghin, Maddalena
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2024, 29 (02) : 131 - 137
  • [26] Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir
    Fellay, J
    Venetz, JP
    Aubert, JD
    Seydoux, C
    Pascual, M
    Meylan, PRA
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 949 - 951
  • [27] Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
    Vernooij, Robin W. M.
    Michael, Mini
    Ladhani, Maleeka
    Webster, Angela C.
    Strippoli, Giovanni F. M.
    Craig, Jonathan C.
    Hodson, Elisabeth M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (05):
  • [28] Clinical utility of cytomegalovirus viral load in solid organ transplant recipients
    Dioverti, Maria V.
    Razonable, Raymund R.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (04) : 317 - 322
  • [29] Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention
    Tsai, Karen C.
    Danziger-Isakov, Lara A.
    Banach, David B.
    CURRENT INFECTIOUS DISEASE REPORTS, 2016, 18 (02) : 1 - 10
  • [30] Clinical Aspects of Cytomegalovirus Antiviral Resistance in Solid Organ Transplant Recipients
    Le Page, A. K.
    Jager, M. M.
    Iwasenko, J. M.
    Scott, G. M.
    Alain, S.
    Rawlinson, W. D.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (07) : 1018 - 1029
12345